Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05813067 · ClinicalTrials.gov registry record · NA
Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women
A NA study, sponsored by Bonafide Health.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT05813067 is a NA study that has completed, run by Bonafide Health. The registered enrollment target is 74 participants.
The verdict
NCT05813067, a NA study, has completed, sponsored by Bonafide Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
The role of nutrition is recognized as a vital component to healthy aging throughout menopause. The goal of this study is to evaluate a dietary supplement for its safety and effects on vasomotor symptoms in menopausal women.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT JDS-HF 3.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2022-12-27 |
| Est. Completion | 2024-04-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05813067
The ClinicalTrials.gov registry entry for NCT05813067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bonafide Health, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05813067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05813067 about?
NCT05813067 is a clinical study titled "Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women". The role of nutrition is recognized as a vital component to healthy aging throughout menopause. The goal of this study is to evaluate a dietary supplement for its safety and effects on vasomotor symptoms in menopausal women.
What is the current status of trial NCT05813067?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2022-12-27. Estimated completion is 2024-04-23.
What interventions are being tested in trial NCT05813067?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), JDS-HF 3.0 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05813067?
This trial is sponsored by Bonafide Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.